Syngene International Ltd.
Information
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated contract research, development and manufacturing organisation providing scientific services -- from early discovery to commercial supply. Our innovative capabilities for novel molecular entities (NMEs) cater to pharma, biotech, nutrition, animal health, consumer goods and speciality chemical companies
Exhibitor Access Type
In-person & Online
Sub-event
ICSE
Zone
CRO & Clinical Trials Zone
Country
India
Organization Type
Contract Service
Markets Active In
OceaniaNorth America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Booth Location
4J43
Offering
Offering: Products or Services
BiopharmaceuticalsCustom ManufacturingContract ServicesPharmaceutical Machinery & Technology
Offering: Biopharmaceuticals
Biopharmaceuticals (general category)
Offering: Contract Services
Contract ManufacturingDevelopment & Validation of Analytical MethodsDrug DiscoveryClinical Research (Field)Contract ResearchFormulation development
Offering: Custom Manufacturing
API Contract ManufacturingCustom Manufacturing (general category)
Offering: Pharmaceutical Machinery & Technology
Drug Formulation (general category)
